Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary

Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...

Descrición completa

Detalles Bibliográficos
Main Authors: Arnon D. Cohen, MD, MPH, PhD, Ronald Vender, MD, FRCPC, Luigi Naldi, MD, Robert E. Kalb, MD, Tiago Torres, MD, PhD, Murlidhar Rajagopalan, MD, Joelle van der Walt, PhD, Lluís Puig, MD (Hon), PhD, Helen S. Young, MB ChB, PhD, FRCP
Formato: Artigo
Idioma:English
Publicado: Elsevier 2020-12-01
Series:JAAD International
Subjects:
biosimilars
interchangeability
International Psoriasis Council
psoriasis
switching
tumor necrosis factor inhibitors
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2666328720300523

Internet

http://www.sciencedirect.com/science/article/pii/S2666328720300523

Títulos similares